Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grimwade

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Blood|August 25, 2001
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialD Grimwade, H Walker, G Harrison, et al.
British Journal of Haematology|September 1, 1996
Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working PartyD Grimwade, K Howe, S Langabeer, et al.
Blood|September 25, 1998
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working PartiesD Grimwade, H Walker, F Oliver, et al.
Leukemia|January 30, 2004
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemiaM D Tischkowitz, N V Morgan, D Grimwade, et al.
British Journal of Haematology|February 13, 2001
EVI1 expression in acute myeloid leukaemiaS E Langabeer, J R Rogers, G Harrison, et al.
Leukemia|November 7, 2008
Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsJ Score, C Walz, J V Jovanovic, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 24, 2011
Molecular pathogenesis of secondary acute promyelocytic leukemiaM Joannides, A N Mays, A R Mistry, et al.
Leukemia|November 1, 2016
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemiaN Khan, R K Hills, P Virgo, et al.
Blood|January 7, 1998
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemiaD Grimwade, P Gorman, E Duprez, et al.
Leukemia|December 11, 2012
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trialA K Burnett, R K Hills, D Grimwade, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood|August 25, 2001
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialD Grimwade, H Walker, G Harrison, et al.
British Journal of Haematology|September 1, 1996
Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working PartyD Grimwade, K Howe, S Langabeer, et al.
Blood|September 25, 1998
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working PartiesD Grimwade, H Walker, F Oliver, et al.
Leukemia|January 30, 2004
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemiaM D Tischkowitz, N V Morgan, D Grimwade, et al.
British Journal of Haematology|February 13, 2001
EVI1 expression in acute myeloid leukaemiaS E Langabeer, J R Rogers, G Harrison, et al.
Leukemia|November 7, 2008
Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsJ Score, C Walz, J V Jovanovic, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 24, 2011
Molecular pathogenesis of secondary acute promyelocytic leukemiaM Joannides, A N Mays, A R Mistry, et al.
Leukemia|November 1, 2016
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemiaN Khan, R K Hills, P Virgo, et al.
Blood|January 7, 1998
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemiaD Grimwade, P Gorman, E Duprez, et al.
Leukemia|December 11, 2012
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trialA K Burnett, R K Hills, D Grimwade, et al.
Pageof 5